Research ArticleArticle
Open Access
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Regina Kurrasch, Judith C. Brown, Myron Chu, Jenny Craigen, Philip Overend, Bela Patel, Steven Wolfe and David J. Chang
The Journal of Rheumatology July 2013, 40 (7) 1089-1096; DOI: https://doi.org/10.3899/jrheum.121118
Regina Kurrasch
From GlaxoSmithKline (GSK), King of Prussia, Pennsylvania,
USA; Stockley Park,
UK; Stevenage,
UK; and Research Triangle Park, North Carolina,
USA.
Judith C. Brown
Myron Chu
Jenny Craigen
Philip Overend
Bela Patel
Steven Wolfe
REFERENCES
- 1.↵
- Teeling JL,
- Mackus WJ,
- Wiegman LJ,
- van den Brakel JH,
- Beers SA,
- French RR,
- et al.
- 2.↵
- Genovese MC,
- Kaine JL,
- Lowenstein MB,
- Baldassare A,
- Schechtman J,
- Fudman E,
- et al.
- 3.↵
- Goldenberg DM,
- Rossi EA,
- Stein R,
- Cardillo TM,
- Czuczman MS,
- Hernandez-Ilizaliturri FJ,
- et al.
- 4.↵
- Teeling JL,
- French RR,
- Cragg MS,
- van den Brakel J,
- Pluyter M,
- Huang H,
- et al.
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Ostergaard M,
- Baslund B,
- Rigby W,
- Rojkovich B,
- Jorgensen C,
- Dawes PT,
- et al.
- 9.↵
- Emery P,
- Fleischmann R,
- Filipowicz-Sosnowska A,
- Schechtman J,
- Szczepanski L,
- Kavanaugh A,
- et al.
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- Cambridge G,
- Stohl W,
- Leandro MJ,
- Migone T,
- Hilbert DM,
- Edwards JC
- 18.↵
- Fleischmann R,
- Cohen S,
- Pardo P,
- Dessouki E,
- Clowse M,
- Korth-Bradley J,
- et al.
- 19.↵
- Damjanov N,
- Tlustochowicz M,
- Aelion J,
- Dimic M,
- Greenwald M,
- Diehl A,
- et al.
In this issue
The Journal of Rheumatology
Vol. 40, Issue 7
1 Jul 2013
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Regina Kurrasch, Judith C. Brown, Myron Chu, Jenny Craigen, Philip Overend, Bela Patel, Steven Wolfe, David J. Chang
The Journal of Rheumatology Jul 2013, 40 (7) 1089-1096; DOI: 10.3899/jrheum.121118
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Regina Kurrasch, Judith C. Brown, Myron Chu, Jenny Craigen, Philip Overend, Bela Patel, Steven Wolfe, David J. Chang
The Journal of Rheumatology Jul 2013, 40 (7) 1089-1096; DOI: 10.3899/jrheum.121118